WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC BB: NNVC.OB) (the “Company”), presented new preclinical data at the 5th International Bird Flu Conference in Las Vegas on September 28th (http://www.new-fields.com/birdflu5/viewAgenda.php?newsid=2#day2).
